Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles

Recall Type: Drug Recall

Source: FDA Recall Notice

Recall Date: August 10, 2026

Summary: FOR IMMEDIATE RELEASE – August 10, 2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 mL vials to the user level. An internal investigation at the firm found the product to cont

Read the original recall notice

Medication Ingredient Resources

Need to check medication ingredients or possible allergen concerns? Visit PillParser.com for ingredient lookup and RxAllergyScan.com to compare medications against an allergen profile.

← Back to Recalls